IOVANCE BIOTHERAPEUTICS, INC. | Human Resources | Business Contracts

Form of Deferred Stock Unit Notice and Deferred Stock Unit Agreement under the Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on August 4, 2022)

Executive Employment Agreement, effective as of March 15, 2021, by and between Igor Bilinsky, Ph.D. and Iovance Biotherapeutics, Inc (Filed With SEC on May 6, 2021)

Severance Agreement and General Release, effective July 8, 2020, between Iovance Biotherapeutics, Inc. and Timothy Morris (Filed With SEC on August 6, 2020)

Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on August 4, 2022)

Form of Nonqualified Stock Option Award Agreement under the Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended (June 2021 Retention Equity Awards) (Filed With SEC on August 5, 2021)

Form of Stock Unit Notice and Stock Unit Agreement under the Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended (June 2021 Retention Equity Awards) (Filed With SEC on August 5, 2021)

Executive Employment Agreement, effective as of December 14, 2020, by and between Jean-Marc Bellemin and Iovance Biotherapeutics, Inc (Filed With SEC on February 25, 2021)

Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on June 9, 2020)

Form of Incentive Stock Option Agreement under the Genesis Biopharma Inc. 2011 Equity Incentive Plan (Filed With SEC on February 25, 2020)

Form of Non-Qualified Stock Option Agreement under the Genesis Biopharma Inc. 2011 Equity Incentive Plan (Filed With SEC on February 25, 2020)

Form of Incentive Stock Option Agreement under the Lion Biotechnologies, Inc. 2014 Equity Incentive Plan (Filed With SEC on February 25, 2020)

Form of Non-Qualified Stock Option Agreement under the Lion Biotechnologies, Inc. 2014 Equity Incentive Plan (Filed With SEC on February 25, 2020)

Form of Incentive Stock Option Agreement under the Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on February 25, 2020)

Form of Non-Qualified Stock Option Agreement under the Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on February 25, 2020)

Executive Employment Agreement effective as of July 18, 2019, by and between Friedrich-Reinhard Graf Finck von Finckenstein, M.D (Filed With SEC on August 1, 2019)

IOVANCE BIOTHERAPEUTICS, INC. (34) | Human Resources (15)